Ajanta Pharma Limited

NSEI:AJANTPHARM Rapporto sulle azioni

Cap. di mercato: ₹385.8b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Ajanta Pharma Dividendo

Dividendo criteri di controllo 5/6

Ajanta Pharma è una società che paga dividendi con un rendimento attuale pari a 1.23%, ben coperto dagli utili.

Informazioni chiave

1.2%

Rendimento del dividendo

38%

Rapporto di remunerazione

Rendimento medio del settore0.7%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azione₹36.000
Utile per azione₹68.11
Previsione del rendimento del dividendo a 3 anni1.4%

Aggiornamenti recenti sui dividendi

Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Oct 31
Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Recent updates

Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 04
Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next

Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

Aug 01
Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E

With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Jun 01
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case

Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

May 05
Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

Apr 05
Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price

We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Feb 23
We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease

Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Dec 23
Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Aug 26
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Feb 07
These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well

Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Oct 24
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors

Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Aug 25
Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

Jul 19
Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?

A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Apr 28
A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

Mar 14
Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly

I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Feb 06
I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Dec 13
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Oct 31
Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50

Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Sep 22
Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Sep 08
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?

Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Aug 26
Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?

Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Jul 07
Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet

Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Jun 14
Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?

Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

May 15
Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?

Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 10
Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why

Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Mar 11
Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

Feb 24
Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?

The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

Jan 30
The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On

What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Jan 18
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?

Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

Jan 06
Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)

What Percentage Of Ajanta Pharma Limited (NSE:AJANTPHARM) Shares Do Insiders Own?

Dec 25
What Percentage Of Ajanta Pharma Limited (NSE:AJANTPHARM) Shares Do Insiders Own?

You Have To Love Ajanta Pharma Limited's (NSE:AJANTPHARM) Dividend

Dec 13
You Have To Love Ajanta Pharma Limited's (NSE:AJANTPHARM) Dividend

Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Recent Stock Performance Influenced By Its Financials In Any Way?

Dec 01
Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Recent Stock Performance Influenced By Its Financials In Any Way?

With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Is Interesting

Nov 19
With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Is Interesting

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: I pagamenti dei dividendi di AJANTPHARM sono stati volatili negli ultimi 10 anni.

Dividendo in crescita: I pagamenti dei dividendi di AJANTPHARM sono aumentati negli ultimi 10 anni.


Rendimento dei dividendi rispetto al mercato

Ajanta Pharma Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di AJANTPHARM rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (AJANTPHARM)1.2%
Fondo del 25% del mercato (IN)0.2%
Top 25% del mercato (IN)1.1%
Media del settore (Pharmaceuticals)0.7%
Previsione dell'analista in 3 anni (AJANTPHARM)1.4%

Dividendo notevole: Il dividendo di AJANTPHARM ( 1.23% ) è più alto rispetto al 25% inferiore dei pagatori di dividendi nel mercato Indian ( 0.25% ).

Dividendo elevato: Il dividendo di AJANTPHARM ( 1.23% ) è tra il 25% dei principali pagatori di dividendi nel mercato Indian ( 1.08% )


Distribuzione degli utili agli azionisti

Copertura degli utili: Grazie al suo payout ratio ( 38.3% ) ragionevolmente basso, i pagamenti dei dividendi di AJANTPHARM sono ben coperti dagli utili.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Grazie al suo ragionevole cash payout ratio ( 71.3% ), i pagamenti dei dividendi di AJANTPHARM sono coperti dai flussi di cassa.


Scoprire le società che pagano dividendi forti